Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum GW Pharmaceuticals Plc GWPHV

NDAQ:GWPHV - Post Discussion

GW Pharmaceuticals Plc > If GW Pharma gets CBD FDA approved...
View:
Post by Jonzeeeee on Dec 31, 2017 7:17pm

If GW Pharma gets CBD FDA approved...

Imagine what companies like Revive Therapeutics(RVV 42 cents) would blast off to?
Comment by TheMJking on Apr 19, 2018 11:48am
 Isol as well. Would be a nice boost to the sector!
Comment by serendipidy on May 24, 2018 5:09pm
kaly therapeutics ( kaly) is poised to skyrocket if CBD gains FDA approval.
Comment by indaknownewfie on May 27, 2018 9:45pm
Bought lots, totally undervalued and GW Pharma leading the way
Comment by Kingofstockst on Jun 17, 2018 10:03am
I agree 100% been doing major dd on kaly and wow that company will be the next one to pop unreal what they have and at these low prices hurry ppl won't last kaly to the bank.
Comment by motamota on Jun 25, 2018 6:47pm
Kaly results due in Q4 re. FDA approval. Pretty awesome overall for medical cannabis. Well done GW!!  
GW Pharmaceuticals Plc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities